Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Warden

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
BMC Cancer|February 26, 2014
Wnt modulates MCL1 to control cell survival in triple negative breast cancerLixin Yang, Aldwin Apollo Perez, Sayuri Fujie, et al.
BMC Cancer|January 23, 2019
CCNE1 amplification is associated with poor prognosis in patients with triple negative breast cancerZi-Ming Zhao, Susan E Yost, Katherine E Hutchinson, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 24, 2019
Molecular Mechanisms of Polybrominated Diphenyl Ethers (BDE-47, BDE-100, and BDE-153) in Human Breast Cancer Cells and Patient-Derived XenograftsNoriko Kanaya, Lauren Bernal, Gregory Chang, et al.
Virology|August 5, 2019
Identification of multiple potent neutralizing and non-neutralizing antibodies against Epstein-Barr virus gp350 protein with potential for clinical application and as reagents for mapping immunodominant epitopesLorraine Z Mutsvunguma, Esther Rodriguez, Gabriela M Escalante, et al.
Molecular Cancer Research : MCR|September 4, 2014
RNA-seq reveals aurora kinase-driven mTOR pathway activation in patients with sarcomatoid metastatic renal cell carcinomaSumanta K Pal, Miaoling He, Tommy Tong, et al.
Communications Biology|November 9, 2019
Single-cell RNA-sequencing analysis of estrogen- and endocrine-disrupting chemical-induced reorganization of mouse mammary glandNoriko Kanaya, Gregory Chang, Xiwei Wu, et al.
Oncotarget|July 3, 2018
ERα-mediated cell cycle progression is an important requisite for CDK4/6 inhibitor response in HR+ breast cancerKarineh Petrossian, Noriko Kanaya, Chiao Lo, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 25, 2018
Rlip depletion prevents spontaneous neoplasia in TP53 null miceSanjay Awasthi, Joshua Tompkins, Jyotsana Singhal, et al.
Iscience|August 9, 2023
Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitorsLinlin Guo, Atish Mohanty, Sharad Singhal, et al.
Nature Communications|February 4, 2016
Downregulation of TLX induces TET3 expression and inhibits glioblastoma stem cell self-renewal and tumorigenesisQi Cui, Su Yang, Peng Ye, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
BMC Cancer|February 26, 2014
Wnt modulates MCL1 to control cell survival in triple negative breast cancerLixin Yang, Aldwin Apollo Perez, Sayuri Fujie, et al.
BMC Cancer|January 23, 2019
CCNE1 amplification is associated with poor prognosis in patients with triple negative breast cancerZi-Ming Zhao, Susan E Yost, Katherine E Hutchinson, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 24, 2019
Molecular Mechanisms of Polybrominated Diphenyl Ethers (BDE-47, BDE-100, and BDE-153) in Human Breast Cancer Cells and Patient-Derived XenograftsNoriko Kanaya, Lauren Bernal, Gregory Chang, et al.
Virology|August 5, 2019
Identification of multiple potent neutralizing and non-neutralizing antibodies against Epstein-Barr virus gp350 protein with potential for clinical application and as reagents for mapping immunodominant epitopesLorraine Z Mutsvunguma, Esther Rodriguez, Gabriela M Escalante, et al.
Molecular Cancer Research : MCR|September 4, 2014
RNA-seq reveals aurora kinase-driven mTOR pathway activation in patients with sarcomatoid metastatic renal cell carcinomaSumanta K Pal, Miaoling He, Tommy Tong, et al.
Communications Biology|November 9, 2019
Single-cell RNA-sequencing analysis of estrogen- and endocrine-disrupting chemical-induced reorganization of mouse mammary glandNoriko Kanaya, Gregory Chang, Xiwei Wu, et al.
Oncotarget|July 3, 2018
ERα-mediated cell cycle progression is an important requisite for CDK4/6 inhibitor response in HR+ breast cancerKarineh Petrossian, Noriko Kanaya, Chiao Lo, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 25, 2018
Rlip depletion prevents spontaneous neoplasia in TP53 null miceSanjay Awasthi, Joshua Tompkins, Jyotsana Singhal, et al.
Iscience|August 9, 2023
Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitorsLinlin Guo, Atish Mohanty, Sharad Singhal, et al.
Nature Communications|February 4, 2016
Downregulation of TLX induces TET3 expression and inhibits glioblastoma stem cell self-renewal and tumorigenesisQi Cui, Su Yang, Peng Ye, et al.
Pageof 4